In fact, in the clinical evidence, in the patients with metastatic or advanced CRC, lower TYMS expression level in cancer tissues is indeed a better outcome to 5-FU-included chemotherapy compared with the higher expression level [27,28]. Here, TYMS is linked to colorectal carcinoma.